Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 55 for “"Solid malignancies"”.
-
The Clinical Significance of HPRT as a Diagnostic and Therapeutic Biomarker for Hematological and Solid Malignancies
… and possible treatment of hematological and solid malignancies. We describe the general upregulation of HPRT upon malignancy and show that this elevation in protein expression is independent of stage, which indicates that it would be useful as an early stage diagnostic companion tool. We have …
-
Optimisation of cell-free DNA analysis methods for solid malignancies: Making more of the data we have
Can we detect cancer in the blood of patients? Yes, we can in many ways – by means of ‘liquid biopsies’. But how we can detect it in the best and most reliable way, science hasn’t decided yet. In this thesis we investigate ways to optimally utilise existing technologies in the field of liquid …
-
ICU, hospital and one year mortality of patients suffering from solid or haematological malignancies
… evolution and outcome of patients suffering from malignancies admitted to a medical intensive care unit. PATIENTS AND METHODS: Single centre retrospective cohort study of patients with malignancies. Data on demographics, diagnosis laboratory tests, provided therapy and outcome were retrospectively …
-
Επίδραση της χορήγησης εποετίνης - Α 40.000 IU για την αντιμετώπιση της αναιμίας χρονίας νόσου σε ασθενείς με συμπαγείς όγκους: κλινική-εργαστηριακή μελέτη
… iron as a therapeutic regimen for patients with solid malignancies and anemia of chrome disease (ACD), not receiving chemotherapy and/or radiotherapy. Methods: A total of 100 patients with cancer-related anemia not subjected to chemotherapy and/or radiotherapy were randomized to receive for a …
-
Phenotypic and Functional Characterization of Surgery Induced Myeloid Derived Suppressor Cells
… is critical for the recovery of patients with solid malignancies. Surgery, however, induces many physiological changes which impair both NK cell cytotoxicity and cytokine secretion giving circulating tumor cells an opportunity to escape and form distant metastases. The rise of MDSCs in the …
-
THE BTLA-HVEM AXIS RESTRAINS CHIMERIC ANTIGEN RECEPTOR T CELLS AGAINST CANCER
… of Hodgkin lymphoma, non-Hodgkin lymphoma, and solid malignancies. Overall, our data suggest that the BTLA-HVEM axis is a crucial immune checkpoint in CAR T cell immunotherapy and warrants the use of novel strategies to overcome this barrier.
-
Surgical Stress Attenuates Pre-existing Anti-tumour Immunity Resulting in Postoperative Metastases and local Recurrence in a Murine Model
Solid malignancies in cancer patients require surgical intervention; however, surgery has been shown to promote the metastatic potential of tumour cells. Surgery-induced impairment of adaptive immunity is poorly understood, thus, our aim is to characterize the impact of surgery on tumour …
-
Potentiating oncolytic virus therapy for the treatment of Acute Myeloid Leukaemia
… whilst OV have demonstrated promising results in solid malignancies, their potential for the treatment of AML remains poorly understood. Therefore, herein, we have investigated the efficacy of OVs against AML and developed a combination approach to boost OV efficacy. Using a panel of OV; reovirus, …
-
The role of oncolytic virus-induced anti-tumour immunity in haematological malignancies
Haematological malignancies (HM) are a diverse group of relatively rare, but often life-threatening cancers. Over 900 000 people worldwide are expected to receive a HM diagnosis in 2018. Most types of HM have an increasing incidence with age, which is often associated with poor survival due to the …
-
Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies
… female, 19 male, median age 63) with refractory solid malignancies were treated with four successive dose levels (45mg/m²/day to 200mg/m²/day) intravenously over one hour on five consecutive days every three weeks. Overall, 62 cycles were administered. Most frequent non-hematological adverse …
-
Comparing Tumor-Specific CD8+ T Cells in the Bone Marrow with Tumor Infiltrating Lymphocytes: Implications for Adoptive Cell Therapy in Solid Tumors
… including tumor-associated antigens from certain solid cancers. BM T cells possess an enhanced reactivity to a variety of hematologic and solid cancers as compared to T cells from the peripheral blood. As TILs are an approved treatment modality for at least two types of solid tumors, t¬¬his …
-
Development and preclinical evaluation of tumour-reactive T cells expressing a chemically programmable chimeric antigen receptor
… rates of sustained complete remissions in B cell malignancies. However, the downregulation or loss of the targeted antigen after mono-specific CAR T cell therapy, e.g. against CD19 or CD22, has been reported. Targeting multiple antigens on tumour cells, sequentially or simultaneously, could …
-
Δημιουργία και χαρακτηρισμός καρκινικών μοντέλων σε ποντίκια για προκλινικές μελέτες
… genes with the highest mutation frequencies in solid malignancies are members of the KMT2 family, whose function is histone 3 lysine 4 methylation. This histone modification has been associated with open chromatin structure. Open chromatin facilitates a number of processes involving the DNA such …
-
Biomarker Analysis and Clinical Relevance of Thymidine Kinase 1 in Solid and Hematological Malignancies
… with the plasma membrane of hematological malignancies such as Burkitt's lymphoma, acute lymphoblastic leukemia, acute promyelocytic leukemia, acute T cell lymphoma, and solid malignancies such as lung, breast, and colon cancer. We also describe the different oligomeric TK1 forms that are …
-
Exploiting the Antitumor Immune Response Using IL-12 Armed Oncolytic MG1 Virus In An Infected Cell Vaccine
… have demonstrated efficacy in selected solid malignancies but their potential in PC is poorly explored. Here I report that intraperitoneal injection of an infected cell vaccine (ICV), consisting of autologous tumor cells infected ex-vivo with an oncolytic Maraba MG1 virus expressing …
-
Examining Post-Operative Antigen Specific CD8⁺ T Cell Dysfunction
… most effective approach to cure patients with solid malignancies. However, surgical trauma results in significant cellular immunosuppression. CD8⁺ T cell dysfunction post-operatively has been characterized, however the effects of surgery on antigen specific CD8⁺ T cell suppression has not been …
-
An Investigation of Chromatin Dynamics in Natural Killer Cells After Tumour Resection to Identify Therapeutic Targets Against Postoperative Anti-Tumour Immune Dysfunction
… improving the overall survival of patients with solid malignancies, yet surgery paradoxically generates an environment that favours residual disease, in part through widespread immunosuppression. Natural killer (NK) cells are key mediators of anti-tumour immunity and their postoperative …
-
Deciphering and Targeting ALK- and ROS1-Driven Pediatric Gliomas
… nervous system (CNS) tumors are the most common solid malignancies in children and a leading cause of cancer-related mortality. In the 5th edition of the WHO Classification of Central Nervous System (CNS) Tumors (WHO CNS5), a key advancement was the integration of molecular profiling to enhance …
-
Single-cell atlas of pancreatic cancer reveals microenvironment ecosystems associated with prognosis and treatment responses
… (PDAC) remains one of the most lethal solid malignancies. The tumour microenvironment (TME), comprising of diverse malignant, stromal, and immune cell states, exhibits significant heterogeneity which profoundly influences patient prognosis, metastatic potential, and treatment responses. …
-
T cell Immunity in Pancreatic Cancer is Undermined by Dendritic Cell Dysfunction
… therapies in pancreatic cancer and similar solid malignancies.
Page 1 of 3